Stacie Liebelt
Family · Riverbank, CANPI 1295779387
Payments from drug & device makers
Across 173 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$839
- Boehringer Ingelheim$506
- Lilly USA, LLC$419
- Bayer$204
- Esperion Therapeutics, Inc.$182
- Biohaven Pharmaceutical Holding Company Ltd.$172
- plus $894 from 19 others
What the payments were for
- Food & beverage$3,216100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 10 | $839 |
| Boehringer Ingelheim | 37 | $506 |
| Lilly USA, LLC | 31 | $419 |
| Bayer | 10 | $204 |
| Esperion Therapeutics, Inc. | 18 | $182 |
| Biohaven Pharmaceutical Holding Company Ltd. | 19 | $172 |
| Lundbeck LLC | 5 | $147 |
| Novo Nordisk | 5 | $98 |
| Sumitomo Pharma America, Inc. | 4 | $91 |
| Sunovion Pharmaceuticals Inc. | 7 | $83 |
| Surgenex LLC | 4 | $71 |
| AbbVie | 4 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Amgen | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Reprise Biomedical, Inc. | 1 | $21 |
| Molnlycke Health Care US, LLC | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| GSK | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Pfizer | 1 | $13 |
| Mylan Specialty L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,216 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 28 | $43,353 |
| EliquisApixaban | 18 | $29,595 |
| MounjaroTirzepatide | 13 | $11,835 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $6,770 |
| MyrbetriqMirabegron | 12 | $6,532 |
| Atorvastatin Calcium | 150 | $1,804 |
| Levothyroxine Sodium | 87 | $1,551 |
| Lisinopril | 81 | $1,248 |
| Omeprazole | 69 | $1,142 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $899 |
| Metformin Hcl | 62 | $884 |
| Potassium Chloride | 39 | $787 |
| Ezetimibe | 28 | $751 |
| Losartan Potassium | 36 | $708 |
| Gabapentin | 24 | $689 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $506 | $43,35328 claims |
| PfizerEliquis | $13 | $29,59518 claims |
| Lilly USA, LLCMounjaro | $419 | $11,83513 claims |
| GSKTrelegy Ellipta | $15 | $6,77011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.
Other family in Riverbank
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.